GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Interest Expense

Biogena Group Invest AG (WBO:BIO) Interest Expense : €0.00 Mil (TTM As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Biogena Group Invest AG's interest expense for the six months ended in Jan. 2024 was € 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jan. 2024 was €0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Biogena Group Invest AG's Operating Income for the six months ended in Jan. 2024 was € 0.00 Mil. Biogena Group Invest AG's Interest Expense for the six months ended in Jan. 2024 was € 0.00 Mil. Biogena Group Invest AG has no long-term debt (1). The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.


Biogena Group Invest AG Interest Expense Historical Data

The historical data trend for Biogena Group Invest AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Interest Expense Chart

Biogena Group Invest AG Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Interest Expense
- - - -

Biogena Group Invest AG Semi-Annual Data
Jan21 Jan22 Jan23 Jan24
Interest Expense - - - -

Biogena Group Invest AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Interest Expense for the trailing twelve months (TTM) ended in Jan. 2024 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogena Group Invest AG  (WBO:BIO) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biogena Group Invest AG's Interest Expense for the six months ended in Jan. 2024 was €0.00 Mil. Its Operating Income for the six months ended in Jan. 2024 was €0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jan. 2024 was €0.00 Mil.

Biogena Group Invest AG's Interest Coverage for the quarter that ended in Jan. 2024 is calculated as

Biogena Group Invest AG had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Biogena Group Invest AG has no debt.


Biogena Group Invest AG (WBO:BIO) Business Description

Traded in Other Exchanges
N/A
Address
Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.